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Distinct regulation of Snail in two muscle lineages of the ascidian
embryo achieves temporal coordination of muscle development
Miki Tokuoka, Kenji Kobayashi and Yutaka Satou*
ABSTRACT
The transcriptional repressor Snail is required for proper differentiation
of the tail muscle of ascidian tadpole larvae. Two muscle lineages
(B5.1 and B6.4) contribute to the anterior tail muscle cells, and are
consecutively separated from a transcriptionally quiescent germ cell
lineage at the 16- and 32-cell stages. Concomitantly, cells of these
lineages begin to express Tbx6.b (Tbx6-r.b) at the 16- and 32-cell
stages, respectively. Meanwhile, Snail expression begins in these two
lineages simultaneously at the 32-cell stage. Here, we show that Snail
expression is regulated differently between these two lineages. In the
B5.1 lineage,Snailwas activated through Tbx6.b, which is activated by
maternal factors, including Zic-r.a. In the B6.4 lineage, the MAPK
pathway was cell-autonomously activated by a constitutively active
form of Raf, enabling Zic-r.a to activate Snail independently of Tbx6.b.
As a result, Snail begins to be expressed at the 32-cell stage
simultaneously in these two lineages. Such shortcuts might be
required for coordinating developmental programs in embryos in
which cells become separated progressively from stem cells, including
germline cells.
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INTRODUCTION
Transcription is repressed in cells with a germ cell fate in many
animal embryos, and somatic lineages are progressively separated
from the germ lineage in some animals, including nematodes and
ascidians (Kumano et al., 2011; Robert et al., 2015; Shirae-
Kurabayashi et al., 2011; Strome and Lehmann, 2007) (Fig. 1). In
the ascidian Ciona intestinalis (type A, also called Ciona robusta),
which is an invertebrate chordate, germ cells are derived from the
most-posterior cells of early embryos. Transcription in this lineage
is repressed by Pem-1, and Pem-1 mRNA is localized at the
posterior pole containing the centrosome-attracting body (Hibino
et al., 1998; Kumano et al., 2011; Shirae-Kurabayashi et al., 2011;
Yoshida et al., 1996). At the 8-cell stage, the vegetal posterior cell
pair, known as B4.1, has the potential to give rise to endoderm,
mesenchyme, notochord, muscle, and germ cells. At the 16-cell
stage, the posterior daughter cells (B5.2) of B4.1 retain the
developmental fates of muscle, mesenchyme, and germ cells, and
transcription is repressed by Pem-1 in these cells. In the anterior
somatic daughter cells (B5.1) of B4.1, several regulatory genes,
including Tbx6.b (Tbx6-r.b), begin to be expressed zygotically. At
the 32-cell stage, the posterior daughter cells (B6.3) of B5.2 again
retain the developmental fates of muscle, mesenchyme, and germ
cells, and transcription is repressed, whereas several regulatory
genes begin to be expressed zygotically in the anterior somatic
daughter cells (B6.4). Thus, at each cell division, the zygotic genetic
program is initiated in the sister cells of those cells with a germ cell
fate. Although both B5.1 and B6.4 cells contribute to muscle and
mesenchyme tissue development, the zygotic genetic programs that
specify these fates do not begin simultaneously.
Snail (Snai), which suppresses Brachyury encoding a notochord-
specific transcriptional activator in muscle cells (Fujiwara et al.,
1998; Kobayashi et al., 2003), begins to be expressed at the 32-cell
stage in the B5.1 and B6.4 lineages simultaneously (Erives et al.,
1998). Snail expression begins one stage later than the initiation of
the zygotic program in the B5.1 lineage, whereas Snail expression
begins immediately after the initiation of the zygotic program in the
B6.4 lineage. However, it is not clear whether Snail expression is
regulated by either a common mechanism or different mechanisms
in these two lineages.
The maternal factor, Zic-r.a (Macho-1), is required for Snail
expression in both the B5.1 and B6.4 lineages (Kobayashi et al.,
2003; Yagi et al., 2004). Zic-r.a mRNA is localized at the posterior
pole, similar to Pem-1 mRNA (Nishida and Sawada, 2001; Satou
et al., 2002). Snail is regulated under the control of Tbx6.b at the
gastrula stage (Imai et al., 2006), and Tbx6.b is activated by Zic-r.a
at the 16-cell stage (Oda-Ishii et al., 2016; Yagi et al., 2004).
Therefore, it is likely that Zic-r.a regulates Snail indirectly through
Tbx6.b in the B5.1 lineage. However, in B6.4 cells, Snail and
Tbx6.b begin to be expressed simultaneously at the 32-cell stage
and, therefore, it is unlikely that Snail expression is regulated
by Tbx6.b in this lineage. Hence, Snail expression might be
regulated differently between the B5.1 and the B6.4 lineages. This
suggests that different mechanisms are required for coordinating
developmental programs in embryos in which somatic cells become
separated progressively from cells with a germ line fate.
In the present study, we demonstrated that Snail is regulated
differently between these two somatic lineages, which are separated
from the germ lineage at the 16-cell and 32-cell stages, respectively.
We also provide evidence that Snail is under the control of the
mitogen-activated protein kinase (MAPK) pathway activated
cell-autonomously by a constitutively active form of Raf.
RESULTS
Snail is required for the proper differentiation ofmuscle cells
Although Snail is known to repress Brachyury, which is a key gene
for notochord specification, in muscle cells (Fujiwara et al., 1998),
no ectopic Brachyury expression has been detected in muscle cells
of Snail morphant embryos [embryos developed from eggs injected
with an antisense morpholino oligonucleotide (MO) against Snail]
(Imai et al., 2006). This implies that Snail is not the only repressor of
Brachyury in the muscle lineage, as previously suggested (Fujiwara
et al., 1998), and that Snail has additional functions in this lineage.Received 28 January 2018; Accepted 3 May 2018
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On the basis of this, we performed an RNA-sequencing (RNA-seq)
experiment to understand the function of Snail. Given that Snail is
expressed not only in the muscle lineage, but also in the neural
lineage, we used partial embryos to examine Snail function in the
muscle lineage.We isolated a pair of vegetal posterior cells (B4.1) at
the 8-cell stage (Fig. 2A), because most muscle cells derive from
this cell pair, and because such partial embryos developmuscle cells
(Deno et al., 1984). We prepared partial embryos from unperturbed
and Snail morphant embryos for RNA-seq. Based on biological
duplicates, we found that 118 genes were expressed differentially
between these two types of partial embryo (P<0.01 and >2-fold-
change; 54 and 64 genes were up- and downregulated in Snail
morphant-derived partial embryos, respectively).
Among these differentially expressed genes, the expression
patterns of 16 of the upregulated genes and 27 of the downregulated
genes have been revealed at the early tailbud stage (Imai et al., 2004;
Miwata et al., 2006; Satou et al., 2001b) (Table S1). Fourteen of the
16 upregulated genes were expressed in the ectoderm (epidermis
and/or nervous system), and 22 of the 27 downregulated genes were
expressed in muscle (Fig. 2B). One of the upregulated genes,Myt1,
which is expressed in the nervous system of unperturbed normal
tailbud embryos (Fig. 2C), was expressed ectopically in the
muscle cells of Snail morphants (n=24, 100%; Fig. 2D). The
downregulation of Mrf, which encodes the sole ortholog of
vertebrate myogenic regulatory factors and is one of the genes
that was downregulated in the RNA-seq experiment, was confirmed
by reverse-transcription followed by quantitative PCR (RT-qPCR)
(Fig. 2E). Consistent with the RNA-seq results, the expression of
these genes was reduced rather than completely lost. Thus, Snail
appears to contribute to the suppression of ectodermal genes and the
activation of muscle genes in muscle cells.
Two regulatory mechanisms for Snail expression in early
embryos
To understand how Snail is activated in the B5.1 and B6.4 lineages,
we first confirmed that Snail expression is under the control of Zic-r.a
at the 32-cell stage. As previously reported (Yagi et al., 2004), Snail
expression was lost in Zic-r.amorphants (Fig. S1). Given that Tbx6.b
is required for Snail expression at the gastrula stage (Imai et al., 2006),
we used in situ hybridization to examine whether Tbx6.b is required
for Snail expression at the 32-cell stage. In Tbx6.b morphants,
whereas Snail expression was diminished in the B5.1 lineage (B6.1
and B6.2), it was observed in the B6.4 lineage (Fig. 3). Thus, the
regulatory mechanism for Snail expression differs between the
anterior B5.1 and posterior B6.4 lineages. In the B5.1 lineage, Snail
expression was regulated under the control of Zic-r.a and Tbx6.b. In
the B6.4 lineage, Snail expression was not regulated by Tbx6.b.
The MAPK pathway is activated differently in the posterior
B-line cells
In contrast to cells of the B5.1 lineage, B6.4 cells begin to express
Snail immediately after release from transcriptional repression in cells
with a germ cell fate. Therefore, it is unlikely that zygotically
expressed transcription factors would regulate Snail in B6.4.
However, we could not rule out the possibility that signaling
molecules secreted from surrounding cells regulate Snail expression.
Given that Fgf9/16/20 begins to be zygotically expressed in vegetal
cells, except B5.2 cells, of 16-cell embryos (Bertrand et al., 2003;
Imai et al., 2002a) and activates genes encoding transcription factors
and signaling molecules in 32-cell embryos (Bertrand et al., 2003;
Hudson et al., 2016; Ikeda et al., 2013; Ikeda and Satou, 2017; Imai
et al., 2002b), we next examined Snail expression in Fgf9/16/20
morphants and embryos treated with U0126, which is a specific
inhibitor of the MAP kinase kinase, MEK. Snail expression did not
change in most of the Fgf9/16/20 morphants (81%; Fig. 4A),
although it was weak in B6.4 cells of the remaining embryos (19%).
Meanwhile, Snail expression in B6.4 cells, but not in the B5.1
lineages (B6.1 and B6.2), was diminished in most of the embryos
treated with U0126 (95%; Fig. 4B). This suggested that activation of
the MAPK pathway is required for activating Snail in B6.4, and that
Fgf9/16/20 signaling is not necessarily required for activating the
MAPK pathway in the posterior lineage.
Immunostaining with antibodies specifically recognizing doubly
phosphorylated ERK (dpERK) showed that this MAPK is activated
in all vegetal cells at the 32-cell stage (Fig. 4C), as well as in the
neural lineages in the animal hemisphere (Haupaix et al., 2013;
Ohta and Satou, 2013; Picco et al., 2007). In Fgf9/16/20morphants,
dpERK signals were lost from all cells except two pairs of the
posterior lineage (B6.3 and B6.4), in which weak signals were
detected (Fig. 4D). Similarly, in embryos injected with synthetic
mRNA for a dominant negative form of the Fgf receptor (dnFGFR)
(Davidson et al., 2006; Hudson et al., 2007), dpERK signals were
lost from all cells except two pairs of the posterior lineage (Fig. 4E).
In embryos treated with U0126, dpERK signals were completely
lost from all cells, including the posterior lineage cells (Fig. 4F).
Quantification of the dpERK signal intensities in nuclei showed that
the intensity in B6.4 was reduced to∼25% in Fgf9/16/20morphants
and embryos injected with dnFGFR mRNA and to almost 0% in
U0126-treated embryos compared with control embryos (Fig. 4G).
Fig. 1. Snail is expressed in the posterior vegetal cells except the most
posterior cells at the 32-cell stage. (A) The cell lineage of posterior vegetal
blastomeres of bilaterally symmetrical Ciona embryos. Cells with a germline
fate with repressed transcription are enclosed by white boxes. The B5.1 and
B6.4 lineages are marked by light gray and dark gray boxes, respectively. The
initiation of zygotic Snail and Tbx6.b expression is indicated above the boxes.
(B) Eight-cell (lateral view), 16-cell (vegetal view) and 32-cell embryos
(vegetal view). B5.1 lineage and the B6.4 lineage cells are filled with light gray
and dark gray, respectively. Sister cells are connected by short lines. Posterior
poles, in which Zic-r.a and Pem-1 are localized, are shown as black ovals.
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As well as the nuclear signal, dpERK signals were also detected
around the posterior pole, where posterior-end-mark mRNAs,
including Zic-r.a and Pem-1, are localized; these signals were lost in
embryos treated with U0126, but not in embryos injected with
the Fgf9/16/20 MO or dnFGFR mRNA (Fig. 4C-F). Thus, the
MAPK pathway is also activated around the posterior pole.
The MAPK pathway can be activated cell-autonomously in
the B6.4 lineage
The above observation implied that the MAPK pathway was
activated cell-autonomously in B6.4 cells. To confirm this
hypothesis, using a glass needle, we consecutively isolated
posterior blastomeres at the 8- and 16-cell stages (Fig. 5A). At the
8-cell stage, we isolated one of the posterior vegetal blastomeres
(B4.1). At this stage, dpERK signals were hardly detected (Fig. 5B).
The isolated blastomere divided unequally into a large blastomere
and a small blastomere at the time when control embryos become
16-cell embryos. These blastomeres were assumed to correspond
to B5.1 and B5.2. Immediately after this division, we again
isolated these two cells, and incubated the smaller one, which we
assumed to correspond to B5.2. With these manipulations, isolated
blastomeres were sequestered from cells with zygotic gene
expression, which included cells expressing Fgf9/16/20; note
that no zygotic transcription has been observed before the 8-cell
stage in this animal. When control embryos became 32-cell
embryos and the isolated blastomere divided into two cells, which
we assumed corresponded to B6.3 and B6.4, we fixed the partial
embryos and examined MAPK pathway activity and the
expression of Snail.
In the experimental embryos, dpERK signals were observed
(Fig. 5C), indicating that the MAPK pathway was activated cell-
autonomously in this lineage. By contrast, a dpERK signal was
rarely observed and was significantly lower in morphant embryos of
Raf, which encodes a MAP kinase kinase kinase (MAP3K)
(Fig. 5D,E). This was also confirmed with another MO targeting
a different region of Raf mRNA (Fig. 5E). This observation
indicated that the cell-autonomous activation of theMAPK pathway
began with Raf or its upstream regulator.
Consistently, Snail was expressed in one cell of this cell pair
derived from uninjected control embryos in all cases (n=7)
(Fig. 5F), and no clear signal for Snail expression was detected in
Fig. 2. RNA-seq identified Snail downstream genes. (A) The experimental design. The posterior vegetal cells (B4.1) of 8-cell embryos were isolated with a fine
glass needle and incubated for an additional 7 h. Gene expression patterns were compared between embryos derived from unperturbed eggs and those
derived from eggs injected with the SnailMO. (B) The graph shows the number of up- and downregulated genes expressed in ectodermal cells and muscle cells.
(C,D)Myt1 expression at the tailbud stage of (C) an unperturbed control embryo and (D) aSnailmorphant embryo (n=24).Myt1 is normally expressed in the nervous
system (white arrowheads). In (D), ectopic expression in muscle cells is evident (black arrowheads). (E) Quantification of Mrf mRNA, which is expressed
specifically inmuscle cells, in control andSnailmorphant embryos at the tailbud stage. Results for six independent experiments are shown by bars of different colors.
Pou2 was used as an internal control for normalization, and the y-axis represents normalized relative expression compared with unperturbed embryos. Differences
in relative expression were analyzed by paired t-tests. Error bars indicate standard errors between technical duplicates. Scale bar: 100 μm.
Fig. 3. Tbx6.b regulates Snail expression only in the B5.1 lineage. Snail
expression in (A) control and (B) Tbx6.b morphant embryos at the 32-cell stage.
Snail expression was lost in the B5.1 lineage (B6.1 and B6.2; arrowheads),
but not in B6.4 of 90% of Tbx6.b morphants (n=22). Scale bar: 100 μm.
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any partial embryos derived from Raf morphants (n=11 for the first
Raf MO, and n=12 for the second MO) (Fig. 5G). Thus, it is likely
that B6.3 and B6.4 activate the MAPK pathway to express Snail in
the absence of a cell–cell interaction, and that Raf functions in this
cell-autonomous pathway.
A splicing variant ofRaf encodes a constitutively active form
of the protein
A gene model for Raf indicated the possibility of two different
transcript isoforms, both of which are supported by multiple
expressed sequence tags (Satou et al., 2005, 2008) (Fig. 6A).
Whereas the protein encoded by the first ‘full’ isoform contained
three domains (CR1, CR2 and CR3) conserved widely from insects
to vertebrates (Daum et al., 1994), the second ‘ΔEx9’ isoform
was produced by skipping the ninth exon and the encoded protein
lacked the second conserved domain (CR2) (Fig. 6B). Reverse
transcription followed by PCR (RT-PCR) revealed that these two
isoforms were present in fertilized eggs and 32-cell embryos
(Fig. 6C).
The CR2 domain contains inhibitory phosphorylation sites, and
mutant proteins with deletions, insertions or mutations of CR2 show
high transforming activity (Chan et al., 2002; Chow et al., 1995;
Heidecker et al., 1990; Ishikawa et al., 1988). Therefore, we tested
the hypothesis that the ΔEx9 isoform acts as a constitutively active
form in the ascidian embryo. For this purpose, we injected Raf
mRNA together with the Fgf9/16/20MO into unfertilized eggs, and
used anti-dpERK antibodies to examine the activity of the MAPK
pathway at the 32-cell stage. As seen in embryos injected with the
Fgf9/16/20MO alone (Fig. 4D), dpERK signals were detected only
in B6.3 and B6.4 in most of the embryos co-injected with the
Fgf9/16/20 MO and the full isoform of Raf mRNA (Fig. 6D). By
contrast, cells with a dpERK signal were markedly increased in
embryos co-injected with the Fgf9/16/20MO and the ΔEx9 isoform
of RafmRNA (Fig. 6E). Indeed, the number of nuclei with a dpERK
signal was significantly higher in the latter embryos than in the
former embryos and in embryos injected with Fgf9/16/20MO only
(Fig. 6H). Cells with a dpERK signal were also increased by
injection of the ΔEx9 isoform of Raf mRNA alone compared with
uninjected control embryos (Fig. 6F,H). Thus, the ΔEx9 isoform
acted as a constitutively active form.
Meanwhile, dpERK signals were lost in embryos that were
injected with the ΔEx9 isoform of Raf mRNA and treated with
U0126, which is a specific inhibitor of MEK (Fig. 6G,H). This
observation suggested that the ΔEx9 isoform of Raf mRNA
activated ERK through MEK, and further supported the
conclusion that the ΔEx9 isoform acted as a constitutively
active form.
Next, we injected mRNA encoding a fusion protein of Raf and a
3xFLAG tag into embryos. As a control, we also injected mRNA
encoding a fusion protein of lacZ and a 3xFLAG tag.
Immunostaining of these embryos with an anti-FLAG antibody
showed that the Raf–3xFLAG fusion protein, but not the lacZ–
3xFLAG fusion protein, was concentrated at the posterior pole
(Fig. 6I,J). Therefore, it is possible that endogenous Raf protein is
also concentrated at the posterior pole.
These results showed that Snail is activated by the combinatorial
action of the MAPK pathway and Zic-r.a in the B6.4 lineage. At the
same time, they raised the question why Snail is not activated in
B5.1 at the 16-cell stage despite the fact that Zic-r.a functions as
early as the 16-cell stage to turn on Tbx6.b, Admp and Wnttun5 in
B5.1 (Oda-Ishii et al., 2016), and that ΔEx9 Raf is expressed in
fertilized eggs (Fig. 6C). To address this question, we quantified the
signaling levels of dpERK in 16-cell embryos, and found that levels
in B5.1 cells of 16-cell embryos were∼20% of those in B6.4 cells of
32-cell embryos (Fig. 7A,B). Therefore, it is likely that the MAPK
pathway activity is not sufficiently strong in B5.1 at the 16-cell stage
to activate Snail. Indeed, bFGF treatment induced Snail expression
in B5.1 of 16-cell embryos, whereas control bovine serum albumin
(BSA) treatment did not (Fig. 7C,D).
The nuclear dpERK signal level was found to be stronger in B5.2
than in the other vegetal blastomeres of 16-cell embryos (B5.1,
A5.1, and A5.2) (Fig. 7A,B). This observation provides further
support for the hypothesis that the MAPK pathway is activated
cell-autonomously in the posterior cells.
Fig. 4. The MAPK pathway is required for
Snail expression in B6.4. (A,B) Snail
expression in (A) Fgf9/16/20 morphant and
(B) U0126 (MEK inhibitor)-treated embryos.
Gray arrowheads in (B) indicate the loss of
Snail expression in B6.4 cells. The number of
embryos examined and the proportion of
embryos that clearly expressed Snail in B6.4
cells are shown within the panels.
(C-F) Immunostaining with the antibody
against dpERK of (C) control, (D) Fgf9/16/20
morphant, (E) dnFGFR mRNA-injected and
(F) U0126-treated embryos. Higher
magnification views for posterior blastomeres
(B6.3 and B6.4) are shown below. In the most
posterior cells (B6.3), the dpERK signal is
observed in nuclei and at the posterior pole
(arrows) in (C-E). Arrowheads in (C-E) indicate
B6.4 cells. Photographs are Z-projected image
stacks. (G) Quantification of fluorescent
intensity in the nuclei of B6.4 cells. The
intensity was measured relative to the DAPI
signal. The y-axis indicates the relative intensity
for the average of the control on a log scale.
Mediansare indicatedbyblackbars.Differences
in relative intensity were analyzed by Wilcoxon
rank-sum tests. Scale bars: 100 μm.
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Two distinct mechanisms for activating Snail expression
Our study showed that Snail is activated by two distinct mechanisms
in early Ciona embryos. In the B5.1 lineage, Snail is activated by
Tbx6.b. This regulation is likely to be direct, because Tbx6.b is bound
to the upstream sequence of Snail in early embryos (Kubo et al.,
2010). Given that Tbx6.b is activated by the combinatorial action of
two maternal factors, β-catenin and Zic-r.a, in B5.1 at the 16-cell
stage (Oda-Ishii et al., 2016), Zic-r.a might indirectly regulate Snail
expression through Tbx6.b in this lineage. By contrast, in the B6.4
lineage, Tbx6.b is not expressed before Snail expression, and is
unnecessary for the activation of Snail. Instead, Zic-r.a and MAPK
pathway activation are required. Given that Snail expression in the
B6.4 lineage begins immediately after the release from transcriptional
repression, it is likely that Zic-r.a directly activates Snail. These
two distinct (Tbx6.b-dependent and MAPK pathway-dependent)
mechanisms cause the simultaneous expression of Snail at the 32-cell
stage in the B5.1 and B6.4 cell lineages (Fig. 7E).
It is possible that the MAPK pathway-dependent mechanism
functions in the B5.1 lineage of 32-cell embryos, because the
MAPK pathway is activated in this lineage at the 32-cell stage
(Fig. 4C). However, cells of the B5.1 lineage (B6.1 and B6.2) are
expected to contain Zic-r.a less abundantly than B6.4 cells, because
B6.4 cells and B6.1/B6.2 cells are daughter and granddaughter cells,
respectively, of the most posterior cells, in which Zic-r.a mRNA is
localized. For this reason, the Tbx6.b-dependent mechanism likely
has the major role in activating Snail in the B5.1 lineage.
Similarly, B5.1 cells of 16-cell embryos might contain Zic-r.a
less abundantly compared with B6.4 cells of 32-cell embryos,
because Zic-r.a is produced from the mRNA localized at the
posterior pole. Therefore, this might be another reason why
the MAPK pathway-dependent mechanism does not function at
the 16-cell stage, in addition to the insufficient level of dpERK in
B5.1 cells of 16-cell embryos shown in Fig. 7B.
The most posterior cells contribute to germ cells, and
transcription in these cells is repressed by Pem-1 (Kumano et al.,
2011; Shirae-Kurabayashi et al., 2011). Given that Zic-r.a and Pem-
1 are both localized at the posterior pole, Zic-r.a cannot activate its
target before Pem-1 disappears. This is the likely reason why Tbx6.b
is not activated in B5.2 (a parental cell of B6.4) at the 16-cell stage;
therefore, the Tbx6.b-dependent mechanism cannot activate Snail in
B6.4 at the 32-cell stage.
Cell-autonomous activation of the MAPK pathway
In normal development, the Fgf9/16/20 signal contributes to
activation of the MAPK pathway in the posterior vegetal cells
(B6.3 and B6.4), as shown by the observation that the dpERK signal
level in Fgf9/16/20morphant embryos was reduced to 25% of that in
unperturbed embryos (Fig. 4G). However, the MAPK pathway was
activated even without this signal. Within the most posterior cells
(B6.3), the dpERK signal was detected in nuclei and at the posterior
pole, where many maternal mRNAs are localized (Matsuoka et al.,
2013; Nishida and Sawada, 2001; Sasakura et al., 1998a,b; Satou,
1999; Satou and Satoh, 1997; Yamada, 2006; Yoshida et al., 1996).
Therefore, it is conceivable that the MAPK pathway is activated by
proteins derived from mRNAs localized at the posterior pole. This
idea is consistent with the observation that activation of the MAPK
pathway in B6.3 and B6.4 does not require signaling molecules from
neighboring cells. Further support comes from the observation that
the dpERK signal was observed in nuclei and at the posterior pole of
the most posterior cells of the 16-cell embryo (Fig. 7A).
A constitutively active form of Raf
Our data strongly suggest that the constitutively active form of Raf
(ΔEx9) is responsible for activation of the MAPK pathway at the
posterior pole. First, the mRNA encoding the constitutively active
form of Raf was present in both fertilized eggs and 32-cell embryos.
Second, Raf activity was required for Snail expression in B6.4.
Third, it is likely that Raf is concentrated at the posterior pole of
Fig. 5. The MAPK pathway is activated autonomously in the B6.4 lineage.
(A) Autonomous activation of the MAPK pathway was examined by isolating
the posterior vegetal cells using a glass needle. At the 8-cell stage, the
posterior vegetal cell, B4.1, was isolated. After the next division, a smaller cell
was again isolated, and the resultant partial embryos were collected after the
next division. (B) Immunostaining with the antibody against dpERK of an 8-cell
embryo (n=57). (C,D) Immunostaining with the antibody against dpERK of
partial embryos obtained from (C) control and (D) Raf morphants embryos.
(E) Quantification of fluorescent intensity in the nuclei of larger cells. The
intensity was measured relative to the DAPI signal. The y-axis indicates the
relative intensity values for the average of the control on a log scale. Medians
are shown by black bars. Differences in relative intensity against the controls
were analyzed by Wilcoxon rank-sum tests. (F,G) In situ hybridization for Snail
mRNA in partial embryos obtained from (F) control (n=7) and (G) Raf
morphants embryos (n=11 for the first Raf MO, and n=12 for the second MO).
Cells with Snail expression in (F) are likely to correspond to B6.4, given their
size. Scale bars: 50 μm.
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early embryos, because the Raf–3xFLAG protein translated from
the injected mRNAwas concentrated at the posterior pole of 32-cell
embryos. However, our data could not discriminate between
whether the injected mRNA was localized at the posterior pole
and thereby its product was observed there, or whether only the
protein product was concentrated at the posterior pole. We favor the
former hypothesis, because endogenous Raf mRNA is weakly
localized at the posterior pole of early embryos (Imai et al., 2004;
Yamada, 2006). Full and ΔEx9 isoforms of Raf might be translated
from mRNA localized in the most posterior cells with a germ cell
fate, and the ΔEx9 isoform diffused from the posterior pole might
activate the MAPK pathway in the most posterior cells (B5.2 of
16-cell embryos and B6.3 of 32-cell embryos) and their daughter
cells (B6.4 of 32-cell embryos). Indeed, the nuclear dpERK signal
level was stronger in B5.2 than in the other vegetal blastomeres
of 16-cell embryos (B5.1, A5.1, and A5.2) (Fig. 7A,B). This
observation supports the former hypothesis that the injected mRNA
was localized in the posterior pole.
Fig. 6. A constitutively active form of Raf
contributes to activation of the MAPK
pathway in the posterior lineage.
(A) Genomic region encoding Raf. Two
gene models, each of which is supported by
ESTs, are predicted (Satou et al., 2008).
(B) An alignment of the amino acid
sequences encoded by the ninth exon of
Ciona Rafwith the corresponding sequence
of human CRAF. The conserved region 2
(CR2) of CRAF is enclosed by a box, and
conserved amino acids between human
and Ciona proteins are shown by asterisks.
(C) Two alternative splicing isoforms are
confirmed by RT-PCR, which was
performed with RNAs extracted from
fertilized eggs and 32-cell embryos.
Locations of primers used for PCR are
shown by arrows on the left.
(D-G) Immunostaining with an antibody
against dpERK. Embryos injected with
(D) Raf mRNA, (E) ΔEx9 Raf mRNA
together with the Fgf9/16/20 MO, and
(F) ΔEx9RafmRNA alone, and (G) embryos
that were injected with ΔEx9 RafmRNA and
treated with U0126 are shown. Photographs
are Z-projected image stacks. Contrast and
brightness of all images were linearly
adjusted. (H) The number of nuclei stained
with the antibody against dpERK was
counted for controls and embryos injected
with the Fgf9/16/20 MO alone or in
combination with the full or ΔEx9 Raf
mRNA. Black bars indicate medians.
Wilcoxon rank-sum tests were performed
among embryos injected with the Fgf9/16/
20 MO and among embryos injected with
ΔEx9 RafmRNA and/or treated with U0126.
(I,J) Immunostaining of embryos injected
with mRNAs encoding proteins of (I) lacZ
and (J) Raf with a 3xFLAG tag (n=40 for I
and n=33 for J). An anti-FLAG antibody was
used in the experiment. Only the Raf protein
is observed at the posterior pole
(arrowheads). Higher magnification views of
the posterior pole are shown in I′ and J′. In I″
and J″, contrast and brightness were
linearly adjusted for clarification. Scale bar:
100 μm.
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Mutant Raf proteins with deletions, insertions or mutations of
CR2 have a high transforming activity (Chan et al., 2002; Chow
et al., 1995; Heidecker et al., 1990; Ishikawa et al., 1988), although
such alternations do not necessarily promote the phosphorylation of
Raf targets in vitro. In the ascidian embryo, the ΔEx9 Raf isoform,
which lacked CR2, behaved as a constitutively active protein, and
increased the level of phosphorylation of ERK. It is well established
that Raf activates MEK, which in turn activates ERK (Imajo et al.,
2006). Indeed, MEK was required for activation of ERK by the
ΔEx9 isoform of Raf in the ascidian embryo (Fig. 6G).
The ΔEx9 isoform was utilized for normal developmental in the
ascidian embryo. It is likely that, because the constitutively active
form of RafmRNAwas a minor population, its protein product does
not activate the MAPK pathway as strongly as Fgf9/16/20. Thus,
despite the constitutive activation of the MAPK pathway, Ciona
embryos will be able to respond to the Fgf9/16/20 signal, which
activates the MAPK pathway more strongly. The activated MAPK
pathway then activates downstream genes in cells other than B6.3
and B6.4 at the 32-cell stage (Bertrand et al., 2003; Hudson et al.,
2016; Imai et al., 2002a; Ohta and Satou, 2013; Ohta et al., 2015).
Hence, the level of activation of the MAPK pathway by the
constitutively active form of Raf will need to be kept low. This will
also be important for preventing this isoform from transforming
embryonic cells. Therefore, RNA processing of Raf transcripts
might be controlled strictly in ascidian embryos.
A shortcut gene circuit for the B6.4 lineage to catch up with
the B5.1 lineage
In the ascidian embryo, somatic cells are separated from cells with
a germ cell fate at each cell division. Given that transcription is
suppressed in the germ line, the zygotic genetic program begins at
different stages; the B6.4 lineage initiates the zygotic genetic
program one stage later than the B5.1 lineage, in which maternal
factors activate Tbx6.b at the 16-cell stage and Tbx6.b activates
Snail at the 32-cell stage. The constitutively active form of
Raf enables Zic-r.a to take a shortcut to directly activate Snail in
the B6.4 lineage; therefore, Snail begins to be expressed
immediately after initiation of the zygotic genetic program at the
32-cell stage (Fig. 7E). As a result, in both the B5.1 and B6.4
lineages, two key transcription factor genes, Tbx6.b and Snail, are
expressed by the 32-cell stage, and the genetic program proceeds
concurrently and in a coordinated manner in these lineages;
Tbx6.b activates the muscle gene circuit, and Snail represses the
ectopic expression of regulatory genes, including Myt1 and
Brachyury. We propose that such shortcuts for gene circuits
might be required for the coordination of cellular developmental
programs in embryos in which somatic cells are produced
progressively from cells with a germ cell fate. Such shortcuts
might also be used for coordination among cells that become
separated progressively from stem cells.
MATERIALS AND METHODS
Animals, whole-mount in situ hybridization, and gene identifiers
C. intestinalis (type A; also called C. robusta) adults were obtained from the
National Bio-Resource Project for Ciona (Japan). cDNA clones were
obtained from our EST clone collection (Satou et al., 2005). Whole-mount
in situ hybridization was performed as described previously (Satou et al.,
1995). Identifiers for genes examined in the present study are as follows:
KH.C3.751 for Snail, KH.L18.20 for Raf, KH.S654.1–3 for Tbx6.b,
KH.C1.727 for Zic-r.a, KH.C2.125 for Fgf9/16/20, KH.C14.307 for Mrf,
and KH.C1.274 for Myt1.
Fig. 7. The MAPK pathway is weakly activated in the
posterior cells of 16-cell embryos. (A) Immunostaining
with an antibody against dpERK in a 16-cell embryo.
Arrowheads indicate the signal for the posterior pole.
(B) Quantification of fluorescent intensity in the nuclei of
four vegetal cells of 16-cell embryos and of B6.4 of 32-cell
embryos. The average intensity was calculated relative to
the DAPI signal. The y-axis indicates the relative values for
the average of the control on a log scale. Differences in
relative intensity between B5.2 and other vegetal
blastomeres of 16-cell embryos and between B5.1 and
B6.4 were analyzed by Wilcoxon rank-sum tests.
(C,D) Snail expression in 16-cell embryos incubated in sea
water containing (C) BSA and (D) recombinant bFGF.
Precocious expression ofSnail in B5.1 in (D) is indicated by
arrows. The number of embryos examined and the
proportion of embryos that expressed Snail are shown
below the panels. (E) Summary of regulation ofSnail. Scale
bars: 100 μm.
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Gene knockdown, overexpression and reporter assays
Sequences of RafMOs were 5′-CATTGTGGCCATCATTCTTTGCCAT-3′
and 5′-AATCTCCTAACTGATCTTCCAGTCA-3′, and sequences of Snail
and Fgf9/16/20 MOs were 5′-GTCATGATGTAATCACAGTAATATA-3′
and 5′-CATAGACATTTTCAGTATGGAAGGC-3′. Snail and Fgf9/16/20
MOs have been used previously (Imai et al., 2006, 2009). Given that Tbx6.b
is a multicopy gene, we injected a mixture of the following two MOs so that
all copies were knocked down, as reported previously (Yagi et al., 2005): 5′-
TTGAGCCTCTCACGTCTGTCGCCAT-3′ and 5′-TTACAATTTCCTC-
TCTCTTTCGATT-3′. MOs were injected by microinjection under a
microscope, as described previously (Satou et al., 2001a).
For RafmRNA injection, the entire coding sequence and coding sequence
lacking the ninth exon of Raf were cloned into pBluscript RN3 (Lemaire
et al., 1995). mRNAs encoding Raf–3xFLAG and the lacZ–3xFLAG tag
contain the 5′ and 3′ untranslated regions of Raf. These mRNAs were
transcribed using the mMESSAGE mMACHINE T3 Transcription Kit
(Thermo Fisher Scientific).
We performed all gene knockdown and/or overexpression experiments at
least twice with different batches of embryos.
RNA sequencing
For RNA-seq experiments, we prepared normal control embryos and
embryos injected with the Snail MO. At the 8-cell stage, we isolated the
posterior vegetal cell pair (B4.1) with a fine glass needle. The isolated cells
were incubated until unperturbed embryos reached the tailbud stage. RNA
was extracted using a Dynabeads mRNA DIRECT Micro Kit (Thermo
Fisher Scientific) and libraries were made with an Ion Total RNA-Seq kit v2
(Thermo Fisher Scientific). The libraries were sequenced with an Ion PGM
instrument (Thermo Fisher Scientific). We performed the same experiment
twice (biological duplicates). NOISeq (Tarazona et al., 2011) was used to
identify differentially expressed genes.
Immunostaining and quantification of fluorescent intensity
Immunostaining with the anti-dpERK antibody (Sigma, M9692) and anti-
FLAG antibody (Sigma, F1840) was performed as described previously
(Ohta and Satou, 2013). ImageJ was used to quantify the fluorescent
intensity. All photographs for comparisons were taken under the same
conditions, and the DAPI signal intensity was used as a reference.
Reverse transcription followed by PCR
To quantify gene expression, we used the Cells-to-Ct kit (Thermo-Fisher
Scientific). For each reaction, 15 embryos were lysed. Each specimen was
divided into two fractions; reverse transcriptase (RT) was added to one
fraction, and water was added into the other fraction as an RT(–) control. No
amplification was observed in the RT(–) controls. Given that Pou2 is
maternally expressed and its expression is thought to remain constant in
early embryos, we used it as an internal control. TaqMan chemistry was used
in quantitative PCR, and the probes and primers are listed in Table S2.
To detect splicing variants of Raf, RNA was extracted using the RNeasy
kit (Qiagen). After DNase treatment, each specimen was reverse transcribed
with SuperScript II RT (Thermo Fisher Scientific), and then amplified with
PCR using the following primers: 5′-GAAGAAAATCCGTCCCCAAAC-
3′ and 5′-GTGGGCGGGCGGATAA-3′. No amplification was observed in
control samples that included water instead of RT.
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Figure S1. Snail is regulated by the maternal factor Zic-r.a. Whole-mount in situ hybridization 
for Snail mRNA in Zic-r.a morphant embryos. Snail expression was not observed in 29 of 30 
embryos examined. Scale bar, 100 μm. 





















Table S1. Differentially expressed genes in Snail morphant partial embryos. 
Gene 
Fold of Change (morphant 
rpkm / control rpkm) 
Expression 
Upregulated genes in Snail morphants 
KH.C4.146 NA (7.74/0) epidermis 
Myt1 (KH.C1.274) 48.93 (15.69/0.32) nervous system, mesenchyme 
Epi1 (KH.C1.188) 42.51 (41.66/0.98) epidermis 
KH.C7.455 25.78 (46.92/1.82) nervous system 
KH.C8.510 19.17 (4.62/0.24) epidermis 
Pitx (KH.L153.79) 13.86 (5.19/0.37) nervous system 
Hes.a (KH.C1.159) 7.94 (49.22/6.19) muscle, epidermis 
KH.S164.13 7.73 (61.28/7.92) notochord, epidermis, endoderm, nervous system 
Snail (KH.C3.751) 5.11 (326.31/63.87) muscle 
KH.S1012.1 3.82 (613.13/160.3) endoderm 
KH.C9.203 2.94 (57.86/19.67) nervous system 
Chd (chordin; KH.C6.145) 2.9 (74.35/25.65) nervous system 
sFRP1/5 (KH.L171.5) 2.54 (145.72/57.45) endoderm, epidermis 
Zf266 (KH.C1.777) 2.33 (90.7/38.86) mesenchyme, notochord, nervous system 
Crebzf.a (KH.L108.4) 2.22 (162.52/73.17) epidermis 
KH.C11.697 2 (116.12/57.96) notochord, endoderm, brain, nervous system 
Downregulated genes in Snail morphants 
Isl (KH.L152.2) 0 (0/3.3) nervous system 
Tbx15/18/22 (VegTR) 
(KH.S589.4) 0.06 (0.97/16.24) muscle 
KH.L84.14 0.06 (2.6/42.3) muscle 
KH.S455.4 0.13 (3.88/30.72) muscle 
Mrf (MyoD) (KH.C14.307) 0.16 (6.64/40.87) muscle 
muscle actin (KH.C1.570) 0.17 (693.63/4049.83) muscle 
KH.C4.231 0.17 (17.51/100.6) muscle, epidermis 
muscle actin (KH.C8.649) 0.17 (38.9/222.85) muscle 
muscle actin (KH.C1.242) 0.19 (670.66/3544.06) muscle 
Hlx (KH.C11.657) 0.2 (12.72/64.59) mesenchyme 
muscle actin (KH.C7.67) 0.22 (352.83/1610.95) muscle 
muscle actin (KH.C4.343) 0.24 (253.08/1067.45) muscle 
muscle creatine kinase 
(KH.L10.5) 0.24 (108.27/455.46) muscle 
myosin light chain 
(KH.C1.1186) 0.24 (317.58/1331.2) 
muscle 
muscle actin (KH.S1440.1) 0.25 (541.25/2159.43) muscle 
myosin regulatory light 
chain (KH.C8.477) 0.28 (543.33/1960.28) muscle 
KH.C7.476 0.28 (31.41/111.06) muscle 
tropomyosin (KH.C3.661) 0.3 (583.28/1965.44) muscle 





















KH.L4.23 0.32 (247.99/765.52) muscle 
myosin regulatory light 
chain (KH.C8.309) 0.35 (476/1372.56) muscle 
KH.C11.121 0.37 (75.89/202.62) muscle, epidermis, endoderm, nervous system, mesenchyme 
KH.S770.1 0.39 (58.4/149.79) epidermis, mesenchyme 
myosin regulatory light 
chain (KH.C8.859) 0.41 (287.26/706.18) muscle 
KH.C14.291 0.45 (80.26/177.22) mesenchyme 
KH.L17.2 0.45 (163.43/360.11) muscle, trunk ventral cells (adult heart precursors) 
Zf306 (KH.C1.669) 0.47 (26.37/56.65) muscle, mesenchyme, notochord, nervous system 
KH.C14.330 0.48 (65.98/136.75) epidermis 





















Table S2. Primers and probes for RT-qPCR. 
Gene Probes and Primers 
Mrf Probe : 5ʹ-FAM-CCCTTAAGCGTTGCGCATGCG-TAMRA-3ʹ 
Forward primer : 5ʹ-CGTGTCAACCAAGCGTACGA-3ʹ 
Reverse primer : 5ʹ-GGAAGTCTCTGGTTCGGGTTT-3ʹ 
Pou2 Probe : 5ʹ-VIC-TGGTCCAGCCAAATCACTCACGCCTA-TAMRA-3ʹ 
Forward primer : 5ʹ-TACCACAGCATACACTGGACAACA-3ʹ 
Reverse primer : 5ʹ-GGCGCTGAGGTAATGCTTTG-3ʹ 
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